Today: 9 June 2026
Singtel stock slides as 50Gbps fibre trial spotlights spend-and-growth questions
7 January 2026
1 min read

Singtel stock slides as 50Gbps fibre trial spotlights spend-and-growth questions

Singapore, January 7, 2026, 15:09 SGT — Regular session

Shares of Singapore Telecommunications Ltd (Singtel) fell about 2.4% to S$4.43 in afternoon trade on Wednesday, as the operator pressed ahead with a 50Gbps fibre broadband trial it announced earlier this week. The stock traded between S$4.42 and S$4.56 on the day and is set to report earnings on Feb. 18.

Singtel has started a technical trial of 50 gigabits per second fibre broadband — the first such operator test in Singapore — and it has not confirmed a timeline for a commercial rollout. The pilot uses XGS-PON (10 Gigabit Symmetrical Passive Optical Network), a fibre access standard, to stress-test whether networks can deliver much higher speeds while keeping latency — the lag in data transfer — low as homes and firms run heavier AI and cloud workloads. “This next evolution in fibre broadband connectivity helps ensure that homes and businesses can continue to support increasingly immersive and AI-enabled digital experiences,” Singtel Singapore CEO Ng Tian Chong said. Computer Weekly

The trial lands as investors look for clearer payoffs from network upgrades in a mature home market, where pricing and product differentiation can be tight. Singtel widened its operating companies’ earnings guidance to “high single digit to low double digit” growth after a strong first half, while its Australian unit Optus remained a focal point after operational setbacks, The Business Times reported.

The broader Singapore market held near record levels, with the Straits Times Index up about 0.02% on Wednesday after a 1.27% jump in the prior session.

But execution risks linger at Optus, which has faced heightened scrutiny after network incidents. A review of a September emergency-call outage found failures during a firewall upgrade and said the Optus board was weighing action “from financial penalties through to termination” for those responsible.

Stock Market Today

  • The Oncology Institute (TOI) Shares Show 38.1% Upside According to Wall Street Analysts
    June 9, 2026, 11:45 AM EDT. Shares of The Oncology Institute, Inc. (TOI) have risen 26.4% in the last four weeks, closing at $5.07. Wall Street analysts set a mean short-term price target of $7, suggesting a potential upside of 38.1%. Targets range from $5.00 to $8.00, reflecting some variability with a standard deviation of $1.41, indicating mixed analyst views. Despite caution over historically optimistic analyst estimates-sometimes influenced by firm relationships-consensus earnings revisions also signal possible stock gains. While analyst price targets offer a snapshot of market sentiment, investors are advised to consider them as part of broader research rather than sole investment criteria.

Latest articles

Coupang Stock Gains as Privacy Ruling Approaches

Coupang Stock Gains as Privacy Ruling Approaches

9 June 2026
Coupang shares jumped 2% to $15.49, outperforming a falling market, as investors braced for South Korea’s privacy regulator to decide June 10 on possible sanctions over a data breach exposing 33.6 million records—a ruling that could trigger fines up to 3% of sales and impact the stock’s recovery.
AEP’s $78 Billion Grid Plan Spurs Data Center Hopes

AEP’s $78 Billion Grid Plan Spurs Data Center Hopes

9 June 2026
AEP lifted its five-year capital plan to $78 billion after signing 7 gigawatts of new large-energy project agreements, with 90% of 63 gigawatts of expected incremental load by 2030 tied to data centers; shares recently traded at $127.27, up 26.9% over 52 weeks, with analysts’ mean price target at $142.76, as investors weigh execution risks and a new data-center rate structure.
Dow climbs in New York, but gains may stall

Dow climbs in New York, but gains may stall

9 June 2026
Dow jumps 154.87 points as tech rebounds and oil prices drop, with chipmakers like Intel and Broadcom up sharply; investors brace for Wednesday’s key inflation data and next week’s Fed meeting, which could sway rate expectations and market direction.
U.S. Stocks Hit Records This Week — Why the S&P 500 and Nasdaq Rally Survived the Oil Shock

Dow Up While Nasdaq Dips; AI Rally Meets Inflation Data

9 June 2026
Nuvalent soared after GSK agreed to buy the cancer drug developer for $10.6 billion in cash, valuing shares at $124—a 40% premium to Monday’s close—while investors awaited Wednesday’s key inflation data that could impact market direction and tech stock stability.
Smart Logistics Jumps 159% Before Nasdaq Halt

Smart Logistics Jumps 159% Before Nasdaq Halt

9 June 2026
Smart Logistics Global soared 158.75% to $1.33 before a Nasdaq volatility pause, putting the stock above the $1 minimum bid-price needed for compliance after months below the threshold; the company must now close at or above $1 for 10 straight business days to avoid further Nasdaq action, with no new company news driving the surge.
Applied Materials stock jumps to a fresh 52-week high as CES AI talk lifts chip-equipment shares
Previous Story

Applied Materials stock jumps to a fresh 52-week high as CES AI talk lifts chip-equipment shares

Intel stock today: INTC steadies before the bell as CES “Panther Lake” chips put 18A under the microscope
Next Story

Intel stock today: INTC steadies before the bell as CES “Panther Lake” chips put 18A under the microscope

Go toTop